These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3007265

  • 1. [Proof of diaplacental transmission of HTLV III/LAV before the 20th week of pregnancy].
    Schäfer A, Jovaisas E, Stauber M, Löwenthal D, Koch MA.
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):88-9. PubMed ID: 3007265
    [Abstract] [Full Text] [Related]

  • 2. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
    Rogers MF, Ewing EP, Warfield D, Hardy AM, Emery DR, Wolf GC.
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
    [Abstract] [Full Text] [Related]

  • 3. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML, Salassa B, Daziano E, Paggi GC.
    Minerva Med; 1986 May 12; 77(20):897-900. PubMed ID: 3014379
    [Abstract] [Full Text] [Related]

  • 4. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS.
    J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168
    [Abstract] [Full Text] [Related]

  • 5. AIDS and HTLV-III/LAV infection: consequences for obstetrics and perinatal medicine.
    Pinching AJ, Jeffries DJ.
    Br J Obstet Gynaecol; 1985 Dec 15; 92(12):1211-7. PubMed ID: 3002418
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG, diMarzo Veronese F, Lee S, Gallo RC.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [Abstract] [Full Text] [Related]

  • 14. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW, Mikovits JA, Kalyanaraman VS, Overton R, Stevenson H, Stromberg K, Herberman RB, Farrar WL, Ortaldo JR.
    J Immunol; 1986 May 15; 136(10):3619-24. PubMed ID: 2422259
    [Abstract] [Full Text] [Related]

  • 15. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 May 23; 35(20):334-9. PubMed ID: 3010072
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.